This is an interventional, multi-center, randomized study. Adults with confirmed covid-19 disease not more than 10 days before enrollment date were recruited (n=361). Patients in same condition who had treated with standard of care were randomly assigned to the control group (n=178). The investigators analyzed the effect of a herbal compound, Xagrotin, and also investigated impact of different characteristics for instance gender, age, duration of disease, smoking habits and concomitant diseases on the outcome.
This is an interventional, multi-center, randomized study that has been performed in an outpatient setting (n=361). Adults with confirmed covid-19 disease not more than 10 days before enrollment date were recruited. Patients in same condition who had treated with standard of care were randomly assigned to the control group (n=178). The investigators analyzed the effect of a herbal compound, Xagrotin, and also investigated impact of different characteristics for instance gender, age, duration of disease, smoking habits and concomitant diseases on the outcome. Adverse events were registered.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
661
A group of patients were treated with Xagrotin with or without standard of care, the control group received stadard of care
Directorate of health of Sulaimani, Iraq -KRG
Sulaymaniyah, Iraq
Mortality
Number of Participants who died by day 30 after the enrollment
Time frame: 30 days
Duration of Disease From Beginning of Treatment
Number of days the patient has experienced the symptoms
Time frame: 30 days
Hospitalization
Number of participants who have been hospitalized for Covid-19
Time frame: 30 days
Duration of Hospitalization When Occurred
Days the participants were hospitalized
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.